COVID-19 Trial Activated in Under a Week Through New Research Program

Cohen Veterans Bioscience is supporting the National Association of Veterans Research Education Foundation (NAVREF) and the new VA Office of Research and Development (ORD) led Partnered Research Program (PRP).

As an outcome of the Access to Clinical Trials (ACT) for Veterans initiative, the PRP increases veterans’ access to high-quality clinical trials to give Veterans access to world-class health solutions. CVB is lending support to NAVREF to help it expand its infrastructure, including the employment of clinical trial facilitators who will help expedite study start-up at VA trial sites.

The launch of the PRP has led to significant reforms in the VA clinical trial process. The most important of these reforms, allowing clinical trial sponsors to use commercial institutional review boards (IRBs), was finalized in March. As a result, when the COVID-19 pandemic hit, the VA was ready to help lead the clinical research response. Since its launch, the VA has launched trial sites in days, not months, including a partnership with the National Institute of Allergy and Infectious Diseases (NIAID) on its COVID-19 trial.

Share this article:

More from CVB

https://www.cohenveteransbioscience.org/wp-content/uploads/2023/07/CVB-CVN-allyson-quote-square.jpg

Cohen Veterans Network Publishes White Paper Providing Recommendations for Measurement-Based Mental Health Care

https://www.cohenveteransbioscience.org/wp-content/uploads/2023/05/CVB-PR_MM-matt_mitchell_quote-1200x670-2.jpg

Cohen Veterans Bioscience Joins Veteran Matthew Mitchell on Military Makeover with Montel to Discuss Traumatic Brain Injury

https://www.cohenveteransbioscience.org/wp-content/uploads/2022/11/cvb-22-jumps-2.jpg

Cohen Veterans Bioscience and 22 Jumps Announce Parachuting with Purpose: Recognizing the Epidemic of Veterans Suicide as a Result of Traumatic Brain Injury (TBI) and PTSD

About Cohen Veterans Bioscience (CVB)

Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.